Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-28474341

RESUMO

The objective was to evaluate whether preoperative administration of dexamethasone improved postoperative nausea and vomiting (PONV), pain and respiratory function tests in women undergoing conservative surgery for breast cancer. This was a controlled clinical trial conducted between June 2013 and October 2014. Eighty patients were evaluated. Patients received a preoperative dose of 8 mg of dexamethasone (n = 40) or placebo (n = 40). The data on PONV and pain intensity was obtained and forced spirometry tests were performed, 1 hr before and at 1, 6, 12 and 24 hr after surgery. Any use of additional analgesic/antiemetic drugs was recorded. Patients were followed until 30 days after surgery for any surgical or medical complications. The pain intensity was lower in the treatment group for all periods; PONV was lower at 6, 12 and 24 hr; Additional analgesics/antiemetics were required less frequently (all p < .05). Both groups exhibited a restrictive ventilatory pattern immediately after surgery, which was reversed in the following hours. However, spirometric values were higher in the dexamethasone group. There were no pulmonary or metabolic complications after surgery. Our conclusions were that dexamethasone significantly reduced the incidences of PONV, pain and improved respiratory parameters, and reduced the need for additional postoperative analgesic and antiemetic drugs.


Assuntos
Adenocarcinoma/cirurgia , Antieméticos/uso terapêutico , Neoplasias da Mama/cirurgia , Dexametasona/uso terapêutico , Mastectomia Segmentar , Dor Pós-Operatória/epidemiologia , Náusea e Vômito Pós-Operatórios/epidemiologia , Transtornos Respiratórios/epidemiologia , Adulto , Idoso , Analgésicos Opioides/uso terapêutico , Método Duplo-Cego , Feminino , Volume Expiratório Forçado , Humanos , Pessoa de Meia-Idade , Morfina/uso terapêutico , Ondansetron/uso terapêutico , Medição da Dor , Dor Pós-Operatória/tratamento farmacológico , Pico do Fluxo Expiratório , Náusea e Vômito Pós-Operatórios/tratamento farmacológico , Cuidados Pré-Operatórios/métodos , Transtornos Respiratórios/fisiopatologia , Espirometria , Capacidade Vital
2.
Actas Dermosifiliogr ; 108(8): 746-751, 2017 Oct.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28625328

RESUMO

BACKGROUND: Platelet-rich plasma (PRP) provides growth factors that stimulate fibroblast activation and induce the synthesis of collagen and other components of the extracellular matrix. The objective of this study was to evaluate the effect of PRP in the treatment of photodamage of the skin of the hands. MATERIAL AND METHODS: Experimental study enrolling persons with photoaged skin on the dorsum of the hands (Glogau photoaging scale, type III, or Fitzpatrick wrinkle classification, type II) were included between August 2012 and January 2013. A histological comparison was made of skin biopsies taken before and after the application of PRP to the skin of the dorsum of the hands. RESULTS: The mean (SD) age of the 18 women enrolled was 47.9 (4.3) years. Histological analysis showed an increase in the number of fibroblasts (P<.001), number of vessels (P<.001), and collagen density (P=.27). These changes produced significant improvements in the Fitzpatrick wrinkle and elastosis scale (P<.001) and in the Glogau photoaging scale (P=.01). CONCLUSIONS: PRP induced a reduction in the manifestations of skin aging, including an improvement in wrinkles and elastosis.


Assuntos
Mãos , Plasma Rico em Plaquetas , Envelhecimento da Pele , Adulto , Biópsia , Contagem de Células , Colágeno/análise , Feminino , Fibroblastos/patologia , Humanos , Injeções Subcutâneas , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Pele/irrigação sanguínea , Pele/química , Pele/patologia , Pele/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA